CARDIOLOGY CLINICAL QUESTIONS Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and gener- ally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibil- ity for any errors or omissions or for the results obtained from use of the informa- tion contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of par- ticular importance in connection with new or infrequently used drugs. CARDIOLOGY CLINICAL QUESTIONS John P. Higgins, MD, MBA, MPHIL, FACC, FACP, FAHA, FASNC, FSGC ACSM Certifi ed Clinical Exercise Specialist & Certifi ed Personal Trainer Associate Professor of Medicine The University of Texas Health Science Center at Houston (UTHealth) Director of Exercise Physiology Memorial Hermann Sports Medicine Institute Chief of Cardiology, Lyndon B. Johnson General Hospital Principal Investigator HEARTS (Houston Early Age Risk Testing & Screening Study) Houston, Texas Asif Ali, MD Clinical Assistant Professor Division of Cardiovascular Medicine The University of Texas Health Science Center at Houston (UTHealth) Memorial Hermann Heart and Vascular Institute Sub-Clinical Investigator HEARTS (Houston Early Age Risk Testing & Screening Study) Houston, Texas David M. Filsoof, MD Division of Cardiovasuclar Medicine Sub-Clinical Investigator of HEARTS (Houston Early Age Risk Testing & Screening Study) University of Texas-Houston Health Science Center Houston, Texas Mayo School of Graduate Medical Education Jacksonville, Florida New York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan Seoul Singapore Sydney Toronto Copyright © 2012 by The McGraw-Hill Companies, Inc. All rights reserved. Except as permitted under the United States Copyright Act of 1976, no part of this publication may be reproduced or distributed in any form or by any means, or stored in a database or retrieval system, without the prior written permission of the publisher. ISBN: 978-0-07-174899-5 MHID: 0-07-174899-7 The material in this eBook also appears in the print version of this title: ISBN: 978-0-07-174898-8, MHID: 0-07-174898-9. All trademarks are trademarks of their respective owners. Rather than put a trademark symbol after every occurrence of a trademarked name, we use names in an editorial fashion only, and to the benefi t of the trademark owner, with no intention of infringement of the trademark. Where such designations appear in this book, they have been printed with initial caps. McGraw-Hill eBooks are available at special quantity discounts to use as premiums and sales promotions, or for use in corporate training programs. To contact a representative please e-mail us at [email protected]. TERMS OF USE This is a copyrighted work and The McGraw-Hill Companies, Inc. (“McGrawHill”) and its licensors reserve all rights in and to the work. Use of this work is subject to these terms. Except as permitted under the Copyright Act of 1976 and the right to store and retrieve one copy of the work, you may not decompile, disassemble, reverse engineer, reproduce, modify, create derivative works based upon, transmit, distribute, disseminate, sell, publish or sublicense the work or any part of it without McGraw-Hill’s prior consent. You may use the work for your own noncommercial and personal use; any other use of the work is strictly prohibited. Your right to use the work may be terminated if you fail to comply with these terms. THE WORK IS PROVIDED “AS IS.” McGRAW-HILL AND ITS LICENSORS MAKE NO GUARANTEES OR WARRANTIES AS TO THE ACCURACY, ADEQUACY OR COMPLETENESS OF OR RESULTS TO BE OBTAINED FROM USING THE WORK, INCLUDING ANY INFORMATION THAT CAN BE ACCESSED THROUGH THE WORK VIA HYPERLINK OR OTHERWISE, AND EXPRESSLY DISCLAIM ANY WARRANTY, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. McGraw-Hill and its licensors do not warrant or guarantee that the functions contained in the work will meet your requirements or that its operation will be uninterrupted or error free. Neither McGraw-Hill nor its licensors shall be liable to you or anyone else for any inaccuracy, error or omission, regardless of cause, in the work or for any damages resulting therefrom. McGraw-Hill has no responsibility for the content of any information accessed through the work. Under no circumstances shall McGraw-Hill and/or its licensors be liable for any indirect, incidental, special, punitive, consequential or similar damages that result from the use of or inability to use the work, even if any of them has been advised of the possibility of such damages. This limitation of liability shall apply to any claim or cause whatsoever whether such claim or cause arises in contract, tort or otherwise. CONTENTS Faculty Advisors .................................................... xiii Preface ................................................................. xv Acknowledgments ................................................... xix Section I. Diagnostic Testing Does my patient need an electrophysiological study? .................................... 2 When do I need to order a stress test? ................... 4 What are the indications/criteria for myocardial perfusion imaging? .............................. 6 Should I refer my patient for coronary angiography? .......................................... 8 When should I order an echocardiogram on my patient, and which type should I order? .......... 10 Does my patient need cardiac pacing? ................. 12 Does my patient need an implantable- cardioverter-defi brillator (ICD)? ......................... 14 Does my patient need further evaluation with cardiac computed tomography? ................... 16 Section II. ACS How do I use a TIMI risk score in the patient with unstable angina/non-ST elevation myocardial infarction (UA/NSTEMI)? ................ 20 What is my initial management of an unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI) patient? ............................ 22 What is my initial management for an acute ST elevation myocardial infarction (STEMI)? ...... 24 v vi CONTENTS What initial reperfusion strategy should I begin in my patient with an acute STEMI? ........ 26 How do you manage a patient post-MI and treat the complications of MI? ...................... 28 How do I manage variant angina? ....................... 30 Should I refer my patient for PCI or CABG? ....... 32 How do I determine the site of STEMI infarct/injury on ECG? .......................... 34 How do I manage a patient with right/inferior myocardial infarction? .................... 36 How to manage a patient with elevated troponins? ............................................. 38 How do I manage a patient with chronic stable angina? ..................................................... 40 Should our patient get an intra-aortic balloon pump placed? ......................................... 42 How do I manage a patient presenting with cocaine-induced chest pain? ........................ 44 Section III. Valvular Disease Does my patient with aortic stenosis need surgery? ..................................................... 48 Does my patient with aortic regurgitation need surgery? ................................. 50 Does my patient with mitral stenosis need surgery? ..................................................... 52 Does my patient with mitral regurgitation need surgery? ..................................................... 54 How do I manage my pregnant patient with mitral stenosis? ........................................... 56 Does my patient with tricuspid regurgitation need surgery? ..................................................... 58 Does my patient have endocarditis? ..................... 60 CONTENTS vii Does my patient need endocarditis prophylaxis? ....................................................... 62 Should I refer my patient with native valve endocarditis for surgery? ............................ 64 How do I medically treat prosthetic valve endocarditis? .............................................. 66 Should I refer my patient with prosthetic valve endocarditis for surgery? ............................ 68 How do I medically treat endocarditis? ................ 70 How to manage an infected pacemaker? .............. 72 Section IV. Cardiac Diseases Does my patient have amyloid cardiomyopathy? ................................................ 76 How do I manage my patient with atypical angina (cardiac syndrome X)? ................ 78 How do I manage acute pericarditis? ................... 80 How do I manage cardiac tamponade? ................ 82 What should I do if I suspect aortic dissection? ......................................................... 84 How do I manage a patient with aortic dissection? ......................................................... 86 How do I manage my patient with a left ventricular thrombus? ......................................... 88 Does my pregnant patient have peripartum cardiomyopathy? ................................................ 90 How do I diagnose a patient with deep venous thrombosis? ............................................ 92 How do I manage a patient with deep venous thrombosis? ............................................ 94 How do I diagnose pulmonary embolism in my patient? .................................................... 96 viii CONTENTS How do I treat my patient with acute pulmonary embolism? ........................................ 98 Does my patient have pheochromocytoma? ....... 100 How do I manage a patient with pheochromcytoma? .......................................... 102 How do you manage a patient with myocarditis? ..................................................... 104 Section V. Examination What are the abnormal pulses in my patient and what cardiac conditions are they associated with? ................................... 108 What is the likely heart murmur I hear? ............. 110 Does my patient need preoperative cardiac testing for noncardiac surgery? .............. 112 How do I interpret my patients Swanz–Ganz catheterization? ............................ 114 Does my patient need screening for an abdominal aortic aneurysm (AAA)? .................. 116 Section VI. Arrhythmias How do I manage the rate and rhythm in my patient with atrial fi brillation? ...................... 120 Should I start coumadin in my patient with atrial fi brillation? ....................................... 122 How do I manage a patient presenting in acute atrial fl utter? ............................................ 124 How do I manage my patient with Brugada syndrome? .......................................... 126 How do I manage 3rd degree atrioventricular block? ...................................... 128 How do I manage my patient with 2nd degree type I (Wenckebach) atrioventricular block? ....... 130 CONTENTS ix How do I manage my patient with 2nd degree type II atrioventricular block? ........................... 132 Is it ok for my patient to consume an energy beverage? .......................................... 134 Does this ECG show changes of hyperkalemia? .................................................. 136 Does this ECG show changes of hypokalemia? ................................................ 138 Does this ECG show changes of hypercalcemia? ............................................. 140 Does this ECG show changes of hypocalcemia? .............................................. 142 Does this ECG show right bundle branch block? ................................................... 144 Does this ECG show left bundle branch block? ................................................... 146 Does this ECG show left ventricular hypertrophy? .................................................... 148 Does this ECG show second degree type I atrioventricular block? ............................. 150 Does this ECG show second degree type II atrioventricular block (Mobitz II)? .................... 152 Does this ECG show third degree atrioventricular block? ...................................... 154 What should I do if my patient has premature ventricular contractions? .................. 156 How do I manage a patient who presents with WPW? ...................................................... 158 How do I acutely manage a patient with torsade de pointes (TdP)? ................................. 160 Does this ECG show Wolff–Parkinson–White syndrome? ....................................................... 162
Description: